Gourlay G K, Willis R J, Lamberty J
Anesthesiology. 1986 Mar;64(3):322-7. doi: 10.1097/00000542-198603000-00004.
This study reports the results of a double-blind, parallel-group comparison of intravenous methadone with morphine for the control of postoperative pain. Twenty patients (ASA Status 1 or 2) undergoing a surgical procedure involving an upper abdominal incision were randomly allocated to the methadone (n = 10) or morphine (n = 10) treatment groups. The patients were administered a 20-mg intraoperative opioid dose and 5-mg intravenous increments of opioid from precoded syringes in response to pain in the recovery and surgical wards. There was no significant difference between the mean +/- SD amount of supplementary methadone (8 +/- 6.3 mg) and morphine (9 +/- 9 mg) required in the recovery ward to provide initial pain control. The time from initial pain control to the first supplementary dose in the surgical ward was significantly different (P less than 0.01) in the methadone group (20.7 +/- 20.2 h) when compared to the morphine group (6.2 +/- 3.0 h). Further, patients required significantly less (P less than 0.001) methadone (11.5 +/- 8.5 mg) than morphine (41 +/- 14.1 mg) in the surgical ward to provide adequate pain relief throughout the duration of the study (i.e., 60 h). There was a significant difference in visual analogue pain scores between the methoadone and morphine groups on postoperative days 1 and 2, suggesting the quality of pain relief was similar for both treatment groups. Blood opioid-concentration monitoring indicated that there was a relationship between blood opioid concentration and pain relief.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究报告了静脉注射美沙酮与吗啡用于控制术后疼痛的双盲、平行组比较结果。20例(ASA身体状况1级或2级)接受上腹部切口手术的患者被随机分配到美沙酮组(n = 10)或吗啡组(n = 10)。患者术中接受20mg阿片类药物剂量,并在恢复室和外科病房根据疼痛情况从预编码注射器中静脉注射5mg阿片类药物增量。在恢复室提供初始疼痛控制时,补充美沙酮(8±6.3mg)和吗啡(9±9mg)的平均±标准差用量之间无显著差异。与吗啡组(6.2±3.0小时)相比,美沙酮组在外科病房从初始疼痛控制到首次补充剂量的时间有显著差异(P<0.01)(20.7±20.2小时)。此外,在整个研究期间(即60小时),外科病房中患者所需的美沙酮(11.5±8.5mg)明显少于吗啡(41±14.1mg)(P<0.001)。术后第1天和第2天,美沙酮组和吗啡组的视觉模拟疼痛评分有显著差异,表明两个治疗组的疼痛缓解质量相似。血液阿片类药物浓度监测表明血液阿片类药物浓度与疼痛缓解之间存在关联。(摘要截短于250字)